 |
|
|
| |
Sustained Improvements in Biomarkers Observed With Fostemsavir in Heavily Treatment-Experienced Adults With
Multidrug-Resistant HIV-1 From the Phase 3 BRIGHTE Study Through Week 240
|
| |
| |
EACS 2023 oct 20
Antonella Castagna,1 Cristina Mussini,2 Josep M. Llibre,3 Andrea Antinori,4 Manyu Prakash,5 Amy Pierce,6 Jose R. Castillo-Mancilla,6 Allan R. Tenorio,6 Marcia Wang,7 Fangfang Du,7 Andrew Clark,5 Max Lataillade8
1Vita-Salute San Raffaele University, Milan, Italy; 2Clinic of Infectious Diseases, AOU Policlinico, and University of Modena and Reggio Emilia, Modena, Italy; 3Hospital Universitari Germans Trias i Pujol, Barcelona, Spain; 4National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS, Rome, Italy; 5ViiV Healthcare, Brentford, UK; 6ViiV Healthcare, Durham, NC, USA; 7GSK, Collegeville, PA, USA; 8ViiV Healthcare, Branford, CT, USA
|
| |
|
|
|
|
|
